The Cystic Fibrosis Foundation recently signed on to a letter with more than 70 organizations in opposition to the Right to Try Act, which passed in the House of Representatives earlier this month.
Site Search
Showing 11 - 20 of 63 results
News
|
|
3 min read
News
|
|
3 min read
News
|
|
1 min read
News
|
|
3 min read
News
|
|
2 min read
News
|
|
2 min read
News
|
|
2 min read
News
|
|
2 min read
News
|
|
1 min read
The U.S. Food and Drug Administration approved the use of lumacaftor/ivacaftor (Orkambi®) today for children with cystic fibrosis ages 2 to 5 who have two copies of the F508del mutation.
News
|
|
3 min read